1. Distribution of microRNA biomarker candidates in solid tissues and body fluids
   Tobias Fehlmann et al, 2016, RNA Biology CrossRef
2. MicroRNA-455-3p functions as a tumor suppressor by targeting eIF4E in prostate cancer
   Yongxiang Zhao et al, 2017 CrossRef
3. miR-21 inhibitor suppresses cell proliferation and colony formation through regulating the PTEN/AKT pathway and improves paclitaxel sensitivity in cervical cancer cells
   Guohui Du et al, 2017 CrossRef
4. Long-term exposure of MCF-7 breast cancer cells to ethanol stimulates oncogenic features
   Robert Gelfand et al, 2017 CrossRef
5. MicroRNAs driving invasion and metastasis in ovarian cancer: Opportunities for translational medicine (Review)
   Carlos Palma Flores et al, 2017 CrossRef
6. Microrna a New Gate in Cancer and Human Disease: A Review
   Ghanbar Mahmoodi Chalbatani et al, 2017, J. of Biological Sciences CrossRef
7. Levels of MicroRNA Heterogeneity in Cancer Biology
   Nina Petrovic et al, 2017, Mol Diagn Ther CrossRef
8. let-7b and let-7c microRNAs promote histone H2B ubiquitylation and inhibit cell migration by targeting multiple components of the H2B deubiquitylation machinery
   A Spolverini et al, 2017, Oncogene CrossRef
9. MicroRNAs as novel biomarkers for colorectal cancer: New outlooks
   Naghmeh Shirafkan et al, 2018, Biomedicine & Pharmacotherapy CrossRef
10. Isoliquiritigenin attenuates MiR-21 expression via induction of PIAS3 in breast cancer cells
    Shilong Ning et al, 2017, RSC Adv. CrossRef
11. Antisense RNA and Cancer
    Zhiguo Wang, 2018 CrossRef
12. Function Control of Anti-microRNA Oligonucleotides Using Interstrand Cross-Linked Duplexes
    Yasuhiro Mie et al, 2018, Molecular Therapy - Nucleic Acids CrossRef
13. Function of miR-146a-5p in Tumor Cells As a Regulatory Switch between Cell Death and Angiogenesis: Macrophage Therapy Revisited
    Elina Simanovich et al, 2018, Front. Immunol. CrossRef
14. Hypoxia- and acidosis-driven aberrations of secreted microRNAs in endometrial cancer in vitro
    Julia Eismann et al, 2017 CrossRef
15. Dickkopf homolog 3 (DKK3 ): A candidate for detection and treatment of cancers?
    Leila Hamzehzadeh et al, 2018, J Cell Physiol CrossRef
16. Melatonin Inhibits the Proliferation of Gastric Cancer Cells Through Regulating the miR-16-5p-Smad3 Pathway
    Chenyu Zhu et al, 2018, DNA and Cell Biology CrossRef
17. Dysregulation of cellular microRNAs by human oncogenic viruses – Implications for tumorigenesis
    Joana M.O. Santos et al, 2018, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
18. Covalent Strategies for Targeting Messenger and Non-Coding RNAs: An Updated Review on siRNA, miRNA and antimiR Conjugates
    Santiago Grijalvo et al, 2018, Genes CrossRef
19. Up-regulated MiR-27-3p promotes the G1-S phase transition by targeting inhibitor of growth family member 5 in osteosarcoma
    Pei Ye et al, 2018, Biomedicine & Pharmacotherapy CrossRef
20. MiR-125b-5p suppressed the glycolysis of laryngeal squamous cell carcinoma by down-regulating hexokinase-2.
    Lian Hui et al, 2018, Biomed Pharmacother CrossRef
21. miRNA-mediated apoptosis activation through TMEM 48 inhibition in A549 cell line
    Feridun Akkafa et al, 2018, Biochemical and Biophysical Research Communications CrossRef
22. Biological role and clinical value of miR-99a-5p in head and neck squamous cell carcinoma (HNSCC): A bioinformatics-based study
    Yu-ting Chen et al, 2018, FEBS Open Bio CrossRef
23. Comparison of the MicroRNA Expression Profiles of Male and Female Avian Primordial Germ Cell Lines
    Bence Lázár et al, 2018, Stem Cells International CrossRef
24. Antiproliferative effect of upregulation of hsa-let-7c-5p in human acute erythroleukemia cells
    Deniz Mortazavi et al, 2018, Cytotechnology CrossRef
25. MiR-323a-3p suppressed the glycolysis of osteosarcoma via targeting LDHA
    Hanwen Chen et al, 2018, Human Cell CrossRef
26. Effect of dietary components on miRNA and colorectal carcinogenesis
    Adewale Oluwaseun Fadaka et al, 2018, Cancer Cell Int CrossRef
27. Peptide-oligonucleotide conjugates exhibiting pyrimidine-X cleavage specificity efficiently silence miRNA target acting synergistically with RNase H
    O. A. Patutina et al, 2018, Sci Rep CrossRef
28. An overview of epigenetic agents and natural nutrition products targeting DNA methyltransferase, histone deacetylases and microRNAs
    Deyu Huang et al, 2018, Food and Chemical Toxicology CrossRef
29. NF-kappaB-inducing kinase in cancer
    Gunter Maubach et al, 2018, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
30. Niacin induces miR-502-3p expression which impairs insulin sensitivity in human adipocytes
    Emilie Montastier et al, 2018, Int J Obes CrossRef
31. Increased serum exosomal miR-134 expression in the acute ischemic stroke patients
    Jingxia Zhou et al, 2018, BMC Neurol CrossRef
32. The critical role of microRNAs in stress response: therapeutic prospect and limitation
    Jie Du et al, 2018, Pharmacological Research CrossRef
33. Modulation of Expression of miRNAs for Therapeutic Effects in Human Malignant Neuroblastoma
    Swapan K. Ray, 2019 CrossRef
34. Cationic Niosomes as Non-Viral Vehicles for Nucleic Acids: Challenges and Opportunities in Gene Delivery
    Santiago Grijalvo et al, 2019, Pharmaceutics CrossRef
35. Improved Loading of Plasma-Derived Extracellular Vesicles to Encapsulate Antitumor miRNAs
    Margherita Alba Carlotta Pomatto et al, 2019, Molecular Therapy - Methods & Clinical Development CrossRef
36. RNAi therapeutic and its innovative biotechnological evolution
    Yuhua Weng et al, 2019, Biotechnology Advances CrossRef
37. Diversity and signature of small RNA in different bodily fluids using next generation sequencing
    Mohamed El-Mogy et al, 2018, BMC Genomics CrossRef
38. Cryptosporidium-host Interaction Alters Regulation of OncomiRNAs and Tumor Suppressor miRNA Expression
    Feyza Basak et al, 2019, J. of Biological Sciences CrossRef
39. Emerging drugs for primary Sjögren’s syndrome
    Saviana Gandolfo et al, 2019, Expert Opinion on Emerging Drugs CrossRef
40. Non-coding RNAs: Regulators of glioma cell epithelial-mesenchymal transformation.
    Sheng Xin et al, 2019, Pathol Res Pract CrossRef
41. A combined experimental and computational study on peptide nucleic acid (PNA) analogues of tumor suppressive miRNA-34a
    Valerio Piacenti et al, 2019, Bioorganic Chemistry CrossRef
42. Exosomal transfer of miR-126 promotes the anti-tumour response in malignant mesothelioma: Role of miR-126 in cancer-stroma communication.
    Massimo Bracci, 0 CrossRef
43. Catalytic Knockdown of miR-21 by Artificial Ribonuclease: Biological Performance in Tumor Model
    Olga A. Patutina et al, 2019, Front. Pharmacol. CrossRef
44. Effects of AntagomiRs on Different Lung Diseases in Human, Cellular, and Animal Models
    Giuseppe Murdaca et al, 2019, IJMS CrossRef
45. MiR-148a inhibits the proliferation and migration of glioblastoma by targeting ITGA9
    Tong-Jiang Xu et al, 2019, Human Cell CrossRef
46. Demonstrating specificity of bioactive peptide nucleic acids (PNAs) targeting microRNAs for practical laboratory classes of applied biochemistry and pharmacology
    Jessica Gasparello et al, 2019, PLoS ONE CrossRef
47. A new function for miRNAs as regulators of autophagy
    Francesca Aredia et al, 2017, Future Medicinal Chemistry CrossRef
48. Exploiting microRNAs As Cancer Therapeutics
    Tamsin Robb et al, 2017, Targ Oncol CrossRef
49. Emerging role of SETDB1 as a therapeutic target.
    Archana Venkataramana Karanth et al, 2017, Expert Opin Ther Targets CrossRef
50. Recent advances in understanding the role of miRNAs in exosomes and their therapeutic potential
    Xiang-yang MIAO, 2017, Journal of Integrative Agriculture CrossRef
51. Antrodia cinnamomea sensitizes radio-/chemo-therapy of cancer stem-like cells by modulating microRNA expression
    Yu-kai Su et al, 2017, Journal of Ethnopharmacology CrossRef
52. Assessment by miRNA microarray of an autologous cancer antigen‐pulsed adoptive immune ensemble cell therapy (AC‐ACT) approach; demonstrated induction of anti‐oncogenic and anti‐PD‐L1 miRNAs
    Masanobu Chinami et al, 2019, Clin Case Rep CrossRef
53. Emerging role of microRNA 628-5p as a novel biomarker for cancer and other diseases
    Leslimar Rios-Colon et al, 2019, Tumour Biol. CrossRef
54. Efficient Delivery of MicroRNA and AntimiRNA Molecules Using an Argininocalix[4]arene Macrocycle
    Jessica Gasparello et al, 2019, Molecular Therapy - Nucleic Acids CrossRef
55. The Formidable Metamorphosis of the Salamander’s Wool: Asbestos from Eternal Material to Awful Pathologies
    Lory Santarelli et al, 2020 CrossRef
56. Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview.
    Cristina Elena Staicu et al, 2020, Cells CrossRef
57. Long non-coding RNA HOTAIR in cervical cancer: Molecular marker, mechanistic insight, and therapeutic target
    Yan-Hui Zhou et al, 2020 CrossRef
58. High Levels of Apoptosis Are Induced in the Human Colon Cancer HT-29 Cell Line by Co-Administration of Sulforaphane and a Peptide Nucleic Acid Targeting miR-15b-5p
    Jessica Gasparello et al, 2020, Nucleic Acid Therapeutics CrossRef
59. NF-κB p65 represses microRNA-124 transcription in diffuse large B-cell lymphoma
    Hyein Shim et al, 2020, Genes Genom CrossRef
60. Anticancer properties and mechanism of action of the quassinoid ailanthone
    Christian Bailly, 2020, Phytotherapy Research CrossRef
61. Mesoporous Silica Nanoparticles as Carriers for Therapeutic Biomolecules
    Rafael R. Castillo et al, 2020, Pharmaceutics CrossRef
62. Epi-drugs as triple-negative breast cancer treatment
    Mouhamed Idrissou et al, 2020, Epigenomics CrossRef
63. Role of microRNA dysregulation in childhood acute leukemias: diagnostics, monitoring and therapeutics: A comprehensive review
    Joanna Szczepanek, 2020, WJCO CrossRef
64. Clinical significance of miRNA‑1 and its potential target gene network in lung squamous cell carcinoma
    Xiaojiao Li et al, 2019, Mol Med Report CrossRef
65. miR‑539 suppresses the proliferation, migration, invasion and epithelial mesenchymal transition of pancreatic cancer cells through targeting SP1.
    Liang Xue et al, 2020, Int J Mol Med CrossRef
66. MiR‑370 promotes apoptosis in colon cancer by directly targeting MDM4
    Xiaogang Shen et al, 2017, Oncol Lett CrossRef
67. Anticancer effect of miR-96 inhibitor in bladder cancer cell lines
    Ting Xu et al, 2018, Oncol Lett CrossRef
68. Targeting miR‑155‑5p and miR‑221‑3p by peptide nucleic acids induces caspase‑3 activation and apoptosis in temozolomide‑resistant T98G glioma cells
    Roberta Milani et al, 2019, Int J Oncol CrossRef
69. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review)
    Alessia Finotti et al, 2018, Int J Oncol CrossRef
70. Multipotent miRNA Sponge-Loaded Magnetic Nanodroplets with Ultrasound/Magnet-Assisted Delivery for Hepatocellular Carcinoma Therapy
    Wei Dong et al, 2020, Mol. Pharmaceutics CrossRef
71. Heat shock protein-27 and MiR-17-5p are novel diagnostic and prognostic biomarkers for hepatocellular carcinoma in Egyptian patients
    Nermin Raafat et al, 2020, Gene Reports CrossRef
72. Construction of a 13‐microRNA‐based signature and prognostic nomogram for predicting overall survival in patients with hepatocellular carcinoma
    Zhihua Zheng et al, 2020, Hepatol Res CrossRef
73. A Distinctive microRNA (miRNA) Signature in the Blood of Colorectal Cancer (CRC) Patients at Surgery.
    Jessica Gasparello et al, 2020, Cancers (Basel) CrossRef
74. The microRNA target site landscape is a novel molecular feature associating alternative polyadenylation with immune evasion activity in breast cancer
    Soyeon Kim et al, 2020 CrossRef
75. MiR-887 Promotes the Progression of Hepatocellular Carcinoma via Targeting VHL
    Wei Zou et al, 2020, Technol Cancer Res Treat CrossRef
76. Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients
    Yusheng Huang et al, 2020, BMC Genomics CrossRef
77. The Role of MicroRNAs in Vitiligo: Regulators and Therapeutic Targets
    Lili Li, 2020, Ann Dermatol CrossRef
78. Feline Mammary Carcinoma: Past, Present and Future
    A. Gameiro et al, 2020 CrossRef
79. MicroRNAs at the Crossroad of the Dichotomic Pathway Cell Death vs. Stemness in Neural Somatic and Cancer Stem Cells: Implications and Therapeutic Strategies
    Andrea Diana et al, 2020, IJMS CrossRef
80. Delivery of Peptide Nucleic Acids Using an Argininocalix[4]arene as Vector
    Alessia Finotti et al, 2021 CrossRef
81. MicroRNAs Associated With a Good Prognosis of Acute Myeloid Leukemia and Their Effect on Macrophage Polarization
    Alexandra Neaga et al, 2021, Front. Immunol. CrossRef
82. miRNA-128 modulates bone neoplasms cells proliferation and migration through the WNT/β-catenin and EMT signal pathways
    Yang Li et al, 2021, J Orthop Surg Res CrossRef
83. MicroRNA-143 Sensitizes Cervical Cancer Cells to Cisplatin: a Promising Anticancer Combination Therapy
    Yalda Baghay Esfandyari et al, 2021, Reprod. Sci. CrossRef
84. Label free detection of miRNA-21 with Electrolyte Gated Organic Field Effect Transistors (EGOFETs)
    Meenu Selvaraj et al, 2021, Biosensors and Bioelectronics CrossRef
85. Ligand decorated biodegradable nanomedicine in the treatment of cancer
    Ejaj Ahmad et al, 2021, Pharmacological Research CrossRef
86. The potential of miRNA-based therapeutics in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection: a review
    Leonny Dwi Rizkita et al, 2021, Journal of Pharmaceutical Analysis CrossRef
87. miRNAs Involved in Esophageal Carcinogenesis and miRNA-Related Therapeutic Perspectives in Esophageal Carcinoma.
    Giovanni Zarrilli et al, 2021, Int J Mol Sci CrossRef
88. Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview.
    Maja Sabol, 0 CrossRef
89. The Role of miR-640: A Potential Suppressor in Breast Cancer via Wnt7b/β-catenin Signaling Pathway
    Chun Tang et al, 2021, Front. Oncol. CrossRef
90. MicroRNAs in Metastasis and the Tumour Microenvironment
    Carla Solé et al, 2021, IJMS CrossRef
91. Small Noncoding RNAs in Knee Osteoarthritis: The Role of MicroRNAs and tRNA-Derived Fragments.
    Julian Zacharjasz et al, 2021, Int J Mol Sci CrossRef
92. MicroRNA-17-5p inhibits thyroid cancer progression by suppressing Early growth response 2 (EGR2).
    Xiang Geng et al, 2021, Bioengineered CrossRef
93. Enzymatic Spermine Metabolites Induce Apoptosis Associated with Increase of p53, caspase-3 and miR-34a in Both Neuroblastoma Cells, SJNKP and the N-Myc-Amplified Form IMR5
    Yuta Kanamori et al, 2021, Cells CrossRef
94. The prognostic significance of microRNA-221 in hepatocellular carcinoma: An updated meta-analysis
    Wenfeng Liu et al, 2021, Int J Biol Markers CrossRef
95. MicroRNAs Patterns as Potential Tools for Diagnostic and Prognostic Follow-Up in Cancer Survivorship
    Ilaria Conti et al, 2021, Cells CrossRef
96. Methylation‐associated silencing of miR‐9‐1 promotes nasopharyngeal carcinoma progression and glycolysis via HK2
    Qian‐Lan Xu et al, 2021, Cancer Sci CrossRef
97. MicroRNA as an Important Target for Anticancer Drug Development
    Zhiwen Fu et al, 2021, Front. Pharmacol. CrossRef
98. Shifting Gears in Precision Oncology—Challenges and Opportunities of Integrative Data Analysis
    Ka-Won Noh et al, 2021, Biomolecules CrossRef
99. Pan-Cancer Analysis Reveals Common and Specific Relationships between Intragenic miRNAs and Their Host Genes
    Baohong Liu et al, 2021, Biomedicines CrossRef
100. Regulatory interplay between microRNAs and WNT pathway in glioma
     Peyman Tabnak et al, 2021, Biomedicine & Pharmacotherapy CrossRef
101. Gene therapy: A promising approach for breast cancer treatment
     Niloufar Tavakoli Dastjerd et al, 2021, Cell Biochem Funct CrossRef
102. Role of MicroRNAs in the Development and Progression of the Four Medulloblastoma Subgroups
     Emilia Bevacqua et al, 2021, Cancers CrossRef
103. Iodine-125 seed represses the growth and facilitates the apoptosis of colorectal cancer cells by suppressing the methylation of miR-615 promoter
     Fenghai Ren et al, 2022, BMC Cancer CrossRef
104. Exosome-derived noncoding RNAs: Function, mechanism, and application in tumor angiogenesis
     Kangkang Yang et al, 2022, Molecular Therapy - Nucleic Acids CrossRef
105. The Roles of microRNAs in Cancer Multidrug Resistance
     Lucia Pavlíková et al, 2022, Cancers CrossRef
106. Circulating microRNAs as potential diagnostic biomarkers and therapeutic targets in prostate cancer: Current status and future perspectives
     Ahmad Movahedpour et al, 2019, J of Cellular Biochemistry CrossRef
107. Combinatorial RNA therapies in cancer immunotherapy: Challenges and directions
     Kevin Holm et al, 2022 CrossRef
108. MiR-26a-5p as a useful therapeutic target for upper tract urothelial carcinoma by regulating WNT5A/β-catenin signaling
     Yueh-Hua Chung et al, 2022, Sci Rep CrossRef
109. miR-34a Enhances the Susceptibility of Gastric Cancer to Platycodin D by Targeting Survivin
     Yao Peng et al, 2019, Pathobiology CrossRef
110. The New Face of a Well-Known Antibiotic: A Review of the Anticancer Activity of Enoxacin and Its Derivatives
     Karolina Jałbrzykowska et al, 2022, Cancers CrossRef
111. Urinary microRNAs and Their Significance in Prostate Cancer Diagnosis: A 5-Year Update
     Jaroslav Juracek et al, 2022, Cancers CrossRef
112. DNA–Liposome Hybrid Carriers for Triggered Cargo Release
     Kevin N. Baumann et al, 2022, ACS Appl. Bio Mater. CrossRef
113. MicroRNAs and Their Big Therapeutic Impacts: Delivery Strategies for Cancer Intervention
     Charles Holjencin et al, 2022, Cells CrossRef
114. Polypharmacology in Drug Design and Discovery—Basis for Rational Design of Multitarget Drugs
     Zhiguo Wang et al, 2022 CrossRef
115. miRacle of microRNA-Driven Cancer Nanotherapeutics
     Goknur Kara et al, 2022, Cancers CrossRef
116. miRNA nanoencapsulation to regulate the programming of the blood-brain barrier permeability BY hypoxia
     Esteban G. Figueroa et al, 2022, Current Research in Pharmacology and Drug Discovery CrossRef
117. Modulatory role of miRNAs in thyroid and breast cancer progression and insights into their therapeutic manipulation
     Rubai Ahmed et al, 2022, Current Research in Pharmacology and Drug Discovery CrossRef
118. Role of Nanotechnology in Overcoming the Multidrug Resistance in Cancer Therapy: A Review
     Suhail Ahmad Mir et al, 2022, Molecules CrossRef
119. Therapeutic potential of targeting mirnas to prostate cancer tumors: using psma as an active target
     Amir Yarahmadi et al, 2022, Molecular & Cellular Oncology CrossRef
120. Integrated analyses identify miR‐34c‐3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma
     Qiaoyou Weng et al, 2020, The FASEB Journal CrossRef
121. Machine Learning Based Methods and Best Practices of microRNA-Target Prediction and Validation
     Neetika Nath et al, 2022 CrossRef
122. Identification of potential microRNA diagnostic panels and uncovering regulatory mechanisms in breast cancer pathogenesis
     Zahra Sharifi et al, 2022, Sci Rep CrossRef
123. Prognostic value of microRNAs in patients with small cell lung cancer: a meta-analysis
     Jun Peng et al, 2022, World J Surg Onc CrossRef
124. miRNAomics in COVID-19
     Bineypreet Kaur et al, 2023 CrossRef
125. MiR-6165 Dysregulation in Breast Cancer and Its Effect on Cell Proliferation and Migration
     Seyed Omar Ebrahimi et al, 2021, Iran South Med J CrossRef
126. Research and Development of Oligonucleotides Targeting MicroRNAs (miRNAs)
     A. L. Malinowska et al, 2019 CrossRef
127. MicroRNA-155 and Disease-Related Immunohistochemical Parameters in Cutaneous Melanoma
     Manal S. Fawzy et al, 2023, Diagnostics CrossRef
128. Combined Treatment of Cancer Cells Using Allyl Palladium Complexes Bearing Purine-Based NHC Ligands and Molecules Targeting MicroRNAs miR-221-3p and miR-222-3p: Synergistic Effects on Apoptosis
     Chiara Tupini et al, 2023, Pharmaceutics CrossRef
129. Hippo-YAP/TAZ signaling in breast cancer: Reciprocal regulation of microRNAs and implications in precision medicine
     Farzad Sadri et al, 2023, Genes & Diseases CrossRef
130. The key role of microRNA-766 in the cancer development
     Jitendra Gupta et al, 2023, Front. Oncol. CrossRef
131. Circular RNA AGAP1 Stimulates Immune Escape and Distant Metastasis in Renal Cell Carcinoma
     ChangGuo Du et al, 2023, Mol Biotechnol CrossRef
132. Angiogenesis and Prostate cancer: microRNAs comes into view
     Jitendra Gupta et al, 2023, Pathology - Research and Practice CrossRef
133. Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
     Bashdar Mahmud Hussen et al, 2023, Military Med Res CrossRef
134. Shear stress and microRNAs for better metastatic cancer management
     Siluveru KrishnaPriya et al, 2023, Biotechnology Progress CrossRef
135. Pancreatic cancer and stem cell
     Aliakbar Yousefi-Ahmadipour et al, 2024 CrossRef
136. Vitamin D and microRNAs: Role in the pathogenesis and prognosis of breast cancer (Review)
     Luca Falzone et al, 2023, Int J Epigen CrossRef
137. Engineered mesoporous silica nanoparticles, new insight nanoplatforms into effective cancer gene therapy
     Razieh Heidari et al, 2023, International Journal of Biological Macromolecules CrossRef
138. Exploring signaling pathway crosstalk in glioma by mapping miRNA and WNT pathways: A review
     Adamu Imam Isa, 2023, International Journal of Biological Macromolecules CrossRef
139. Expression of MicroRNA-200a/b/c in the Mediobasal Hypothalamic Nuclei with Aging
     Valentina V. Porseva et al, 2023, MIRNA CrossRef
140. Bioengineered chimeric tRNA/pre‐miRNAs as prodrugs in cancer therapy
     Fatemeh Rafieenia et al, 2023, Biotechnology Progress CrossRef
141. Drug regulation of microRNA
     A.E. Abaturov et al, 2024, CH CrossRef
142. Utilizing non-coding RNA-mediated regulation of ATP binding cassette (ABC) transporters to overcome multidrug resistance to cancer chemotherapy
     Kenneth K.W. To et al, 2024, Drug Resistance Updates CrossRef
143. Regulation of sirt1 and foxo1 in glucose metabolism of Megalobrama amblycephala
     Qiaoqiao Mu et al, 2024, Gene CrossRef
144. Circular RNA COL1A1 promotes Warburg effect and tumor growth in nasopharyngeal carcinoma
     ZeJun Zhou et al, 2024, Discov Onc CrossRef
145. Interaction between HOTTIP, H19, and HOTAIR long noncoding RNAs and miRNA-152 in cases of HCC caused by HCV infection
     Rady E. El-Araby et al, 2024, Beni-Suef Univ J Basic Appl Sci CrossRef
146. The role of miRNAs as biomarkers in breast cancer
     Temesgen Baylie et al, 2024, Front. Oncol. CrossRef
147. Advances and challenges in gene therapy strategies for pediatric cancer: a comprehensive update
     Amir Kian Moaveni et al, 2024, Front. Mol. Biosci. CrossRef
148. Exploring the role of microRNAs as diagnostic and prognostic biomarkers in canine mammary tumors
     Tiago Ferreira et al, 2024, GeroScience CrossRef
149. Recent Advances in miRNA Delivery Systems
     Ishani Dasgupta et al, 2021, MPs CrossRef
150. Role of miR-24 in Multiple Endocrine Neoplasia Type 1: A Potential Target for Molecular Therapy
     Francesca Marini et al, 2021, IJMS CrossRef
151. Synergistic Effects of A Combined Treatment of Glioblastoma U251 Cells with An Anti-miR-10b-5p Molecule and An AntiCancer Agent Based on 1-(3′,4′,5′-Trimethoxyphenyl)-2-Aryl-1H-Imidazole Scaffold
     Matteo Zurlo et al, 2022, IJMS CrossRef
152. Recent Progress of pH-Responsive Peptides, Polypeptides, and Their Supramolecular Assemblies for Biomedical Applications
     Mingxuan Hou et al, 2024, Biomacromolecules CrossRef
153. The importance of micro-RNA 224-3p in pathogenesis of NonSegmental Vitiligo
     Rehab M. Naguib et al, 2022 CrossRef
154. The genetic variants of miR-1206 and miR-125b in breast cancer patients: in vitro and in silico analysis
     Hamideh Amini Mostafaabadi et al, 2024, Nucleosides, Nucleotides & Nucleic Acids CrossRef
155. Recent advances in mesoporous silica nanoparticles formulations and drug delivery for wound healing
     Razieh Heidari et al, 2024, International Journal of Pharmaceutics CrossRef
156. Biomarkers for Stratification in Colorectal Cancer: MicroRNAs.
     Adewale Oluwaseun Fadaka et al, 2019, Cancer Control CrossRef
157. miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance
     Ali Tavakoli Pirzaman et al, 2023, Technol Cancer Res Treat CrossRef
158. Theranostic potential of miRNAs in oral cancer: An emerging approach for precision oncology
     Tina Sara Biju et al, 2024, Oral Science International CrossRef
159. An Update on Recent Treatment Approaches for Prostate Cancer
     Atefeh Bijanvand et al, 2024 CrossRef
160. Circular RNA LDLRAD3 promotes gastric cancer progression by upregulating COL4A5 through sponging miR-h37
     Chenghui Li et al, 2024 CrossRef
161. A new perspective on diagnostic strategies concerning the potential of saliva-based miRNA signatures in oral cancer
     Monisha Prasad et al, 2024, Diagn Pathol CrossRef
162. Nucleic acid drugs: recent progress and future perspectives
     Xiaoyi Sun et al, 2024, Sig Transduct Target Ther CrossRef
163. Evaluation of tumorigenesis-related miRNAs in breast cancer in Egyptian women: a retrospective, exploratory analysis
     Ghada M. Salum et al, 2024, Sci Rep CrossRef
164. Immunotherapy for Prostate Cancer
     Atefeh Bijanvand et al, 2025 CrossRef
165. Insights into the Biological Properties of Prostate Cancer Stem Cells: Implications for Cancer Progression and Therapy
     Jafar Poodineh et al, 2025, CSCR CrossRef
166. Integrated Analysis of microRNA Targets Reveals New Insights into Transcriptional–Post-Transcriptional Regulatory Cross-Talk
     Simona Panni et al, 2025, Biology CrossRef
167. miRNAs as neuro-oncologic therapeutics: A narrative review
     Nikita Das et al, 2024, Molecular Therapy CrossRef
168. Research Progress on Natural Products That Regulate miRNAs in the Treatment of Osteosarcoma
     Lin Wang et al, 2025, Biology CrossRef